Characteristics of an ideal antihypertensive therapy for elderly hypertensives

L. Hansson, A. Zanchetti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Treatment of hypertension in the elderly has become not only accepted but also a highly ethical, effective and compelling procedure following the many clearly positive reports on the benefits of lowering elevated arterial pressure in elderly patients. So far most intervention studies in elderly hypertensive patients have used diuretics or β-blockers or the two in combination as the moiety by which blood pressure has been lowered. However, from a theoretical point of view, more novel therapies could offer advantages that would translate into an even better reduction of cardiovascular morbidity and mortality than has been obtained with the traditional antihypertensive therapies used so far. Some of the studies in elderly hypertensives that are in progress using angiotensin converting enzyme inhibitors or calcium antagonists as the main therapies, e.g. the STOP-Hypertension-2 Study and the Syst-Eur Study, will be briefly reviewed here as will the large data base on urapidil, a dual action antihypertensive drug used in the treatment of elderly hypertensives. By careful evaluation of the effects of novel antihypertensive drugs, and the already existing data base on urapidil in elderly hypertensive patients, it is likely that still better reduction of risk can be obtained in the elderly hypertensives by the use of more novel therapies than diuretics and β-blockers.

Original languageEnglish
Pages (from-to)68-72
Number of pages5
JournalBlood Pressure, Supplement
Volume4
Issue number3
Publication statusPublished - 1995

Fingerprint

Antihypertensive Agents
Diuretics
Therapeutics
Databases
Hypertension
Risk Reduction Behavior
Angiotensin-Converting Enzyme Inhibitors
Arterial Pressure
Blood Pressure
Calcium
Morbidity
Mortality

Keywords

  • β-blockers
  • Antihypertensive treatment
  • Diuretics
  • Elderly
  • Hypertension
  • Intervention
  • Urapidil

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Characteristics of an ideal antihypertensive therapy for elderly hypertensives. / Hansson, L.; Zanchetti, A.

In: Blood Pressure, Supplement, Vol. 4, No. 3, 1995, p. 68-72.

Research output: Contribution to journalArticle

Hansson, L. ; Zanchetti, A. / Characteristics of an ideal antihypertensive therapy for elderly hypertensives. In: Blood Pressure, Supplement. 1995 ; Vol. 4, No. 3. pp. 68-72.
@article{4e12d26efb84406fbea6e724ce8b59cc,
title = "Characteristics of an ideal antihypertensive therapy for elderly hypertensives",
abstract = "Treatment of hypertension in the elderly has become not only accepted but also a highly ethical, effective and compelling procedure following the many clearly positive reports on the benefits of lowering elevated arterial pressure in elderly patients. So far most intervention studies in elderly hypertensive patients have used diuretics or β-blockers or the two in combination as the moiety by which blood pressure has been lowered. However, from a theoretical point of view, more novel therapies could offer advantages that would translate into an even better reduction of cardiovascular morbidity and mortality than has been obtained with the traditional antihypertensive therapies used so far. Some of the studies in elderly hypertensives that are in progress using angiotensin converting enzyme inhibitors or calcium antagonists as the main therapies, e.g. the STOP-Hypertension-2 Study and the Syst-Eur Study, will be briefly reviewed here as will the large data base on urapidil, a dual action antihypertensive drug used in the treatment of elderly hypertensives. By careful evaluation of the effects of novel antihypertensive drugs, and the already existing data base on urapidil in elderly hypertensive patients, it is likely that still better reduction of risk can be obtained in the elderly hypertensives by the use of more novel therapies than diuretics and β-blockers.",
keywords = "β-blockers, Antihypertensive treatment, Diuretics, Elderly, Hypertension, Intervention, Urapidil",
author = "L. Hansson and A. Zanchetti",
year = "1995",
language = "English",
volume = "4",
pages = "68--72",
journal = "Blood Pressure, Supplement",
issn = "0803-8023",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Characteristics of an ideal antihypertensive therapy for elderly hypertensives

AU - Hansson, L.

AU - Zanchetti, A.

PY - 1995

Y1 - 1995

N2 - Treatment of hypertension in the elderly has become not only accepted but also a highly ethical, effective and compelling procedure following the many clearly positive reports on the benefits of lowering elevated arterial pressure in elderly patients. So far most intervention studies in elderly hypertensive patients have used diuretics or β-blockers or the two in combination as the moiety by which blood pressure has been lowered. However, from a theoretical point of view, more novel therapies could offer advantages that would translate into an even better reduction of cardiovascular morbidity and mortality than has been obtained with the traditional antihypertensive therapies used so far. Some of the studies in elderly hypertensives that are in progress using angiotensin converting enzyme inhibitors or calcium antagonists as the main therapies, e.g. the STOP-Hypertension-2 Study and the Syst-Eur Study, will be briefly reviewed here as will the large data base on urapidil, a dual action antihypertensive drug used in the treatment of elderly hypertensives. By careful evaluation of the effects of novel antihypertensive drugs, and the already existing data base on urapidil in elderly hypertensive patients, it is likely that still better reduction of risk can be obtained in the elderly hypertensives by the use of more novel therapies than diuretics and β-blockers.

AB - Treatment of hypertension in the elderly has become not only accepted but also a highly ethical, effective and compelling procedure following the many clearly positive reports on the benefits of lowering elevated arterial pressure in elderly patients. So far most intervention studies in elderly hypertensive patients have used diuretics or β-blockers or the two in combination as the moiety by which blood pressure has been lowered. However, from a theoretical point of view, more novel therapies could offer advantages that would translate into an even better reduction of cardiovascular morbidity and mortality than has been obtained with the traditional antihypertensive therapies used so far. Some of the studies in elderly hypertensives that are in progress using angiotensin converting enzyme inhibitors or calcium antagonists as the main therapies, e.g. the STOP-Hypertension-2 Study and the Syst-Eur Study, will be briefly reviewed here as will the large data base on urapidil, a dual action antihypertensive drug used in the treatment of elderly hypertensives. By careful evaluation of the effects of novel antihypertensive drugs, and the already existing data base on urapidil in elderly hypertensive patients, it is likely that still better reduction of risk can be obtained in the elderly hypertensives by the use of more novel therapies than diuretics and β-blockers.

KW - β-blockers

KW - Antihypertensive treatment

KW - Diuretics

KW - Elderly

KW - Hypertension

KW - Intervention

KW - Urapidil

UR - http://www.scopus.com/inward/record.url?scp=0028866807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028866807&partnerID=8YFLogxK

M3 - Article

C2 - 8535546

AN - SCOPUS:0028866807

VL - 4

SP - 68

EP - 72

JO - Blood Pressure, Supplement

JF - Blood Pressure, Supplement

SN - 0803-8023

IS - 3

ER -